High frequency of complex TP53 mutations in CNS metastases from breast cancer

British Journal of Cancer

Volumn 106, Issue 2, 2012, Pages 397-404

  Lo Nigro, C ^a   Vivenza, D ^a   Monteverde, M ^a   Lattanzio, L ^a   Gojis, O ^b,e   Garrone, O ^a   Comino, A ^a   Merlano, M ^a   Quinlan, P R ^c   Syed, N ^d   Purdie, C A ^c   Thompson, A ^c   Palmieri, C ^b   Crook, T ^c  

^a S CROCE E CARLE HOSPITAL   (Italy)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d CHARING CROSS HOSPITAL   (United Kingdom)

^e CHARLES UNIVERSITY   (Czech Republic)

Author keywords

breast cancer; CNS metastasis; p53; triple negative breast cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P53;

ARTICLE; BREAST CANCER; CANCER GROWTH; CENTRAL NERVOUS SYSTEM METASTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; HUMAN; MISSENSE MUTATION; PRIORITY JOURNAL;

BASE SEQUENCE; BREAST NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; DNA PRIMERS; FEMALE; GENES, P53; HUMANS; MUTATION;

EID: 84856493411     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.464     Document Type: Article

References (20)

1. Baker L, Quinlan PR, Patten N, Ashfield A, Birse-Stewart-Bell LJ, McCowan C, Bourdon JC, Purdie CA, Jordan LB, Dewar JA, Wu L, Thompson AM (2010) p53 mutation, deprivation and poor prognosis in primary breast cancer. Br J Cancer 102 719-726
2. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, Minn AJ, van de Vijver MJ, Gerald WL, Foekens JA, Massagué J (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459: 1005-1009
3. Crook T, Crossland S, Crompton MR, Osin P, Gusterson BA (1997) p53 mutations in BRCA1-associated familial breast cancer. Lancet 350: 638-639 (Pubitemid 27367803)
4. Ding L, Ellis MJ, Li S, Larson DE, Chen K, Wallis JW, Harris CC, McLellan MD, Fulton RS, Fulton LL, Abbott RM, Hoog J, Dooling DJ, Koboldt DC, Schmidt H, Kalicki J, Zhang Q, Chen L, Lin L, Wendl MC, McMichael JF, Magrini VJ, Cook L, McGrath SD, Vickery TL, Appelbaum E, DeSchryver K, Davies S, Guintoli T, Lin L, Crowder R, Tao Y, Snider JE, Smith SM, Dukes AF, Sanderson GE, Pohl CS, Delahaunty KD, Fronick CC, Pape KA, Reed JS, Robinson JS, Hodges JS, Schierding W, Dees ND, Shen D, Locke DP, Wiechert ME, Eldred JM, Peck JB, Oberkfell BJ, Lolofie JT, Du F, Hawkins AE, O'Laughlin MD, Bernard KE, Cunningham M, Elliott G, Mason MD, Thompson Jr DM, Ivanovich JL, Goodfellow PJ, Perou CM, Weinstock GM, Aft R, Watson M, Ley TJ, Wilson RK, Mardis ER (2010) Genome remodeling in a basal-like breast cancer metastasis and xenograft. Nature 464: 999-1015
5. Girardini JE, Napoli M, Piazza S, Rustighi A, Marotta C, Radaelli E, Capaci V, Jordan L, Quinlan P, Thompson A, Mano M, Rosato A, Crook T, Scanziani E, Means AR, Lozano G, Schneider C, Del Sal G (2011) A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. Cancer Cell 20: 79-91
6. Holstege H, Joosse SA, van Oostrom CT, Nederlof PM, de Vries A, Jonkers J (2009) High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer. Cancer Res 69: 3625-3633
7. Kennecke H, Yerushami R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO, Gelmon K (2010) Metastatic behavior of breast cancer subtypes. J Clin Oncol 28: 3271-3277
8. Klein A, Olendrowitz C, Schmutzler R, Hampl J, Schlag PM, Maass N, Arnold N, Wessel R, Ramser J, Meindl A, Scherneck S, Seitz S (2009) Identification of brain-and bone-specific breast cancer metastasis genes. Cancer Lett 276: 212-220
9. Manié E, Vincent-Salomon A, Lehmann-Che J, Pierron G, Turpin E, Warcoin M, Gruel N, Lebigot I, Sastre-Garau X, Lidereau R, Remenieras A, Feunteun J, Delattre O, de Thé H, Stoppa-Lyonnet D, Stern MH (2009) High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors. Cancer Res 69: 663-671
10. Nishizuka I, Ishikawa T, Hamaguchi Y, Kamiyama M, Ichikawa Y, Kadota K, Miki R, Tomaru Y, Mizuno Y, Tominaga N, Yano R, Goto H, Nitanda H, Togo S, Okazaki Y, Hayashizaki Y, Shimada H (2002) Analysis of gene expression involved in brain metastasis from breast cancer using cDNA microarray. Breast Cancer 9: 26-32
11. Olivier M, Langerod A, Carrieri P, Bergh J, Klaar S, Eyford J, Theillet C, Rodriguez C, Lidereau R, Bieche I, Varley J, Bignon Y, Uhrhammer N, Winqvist R, Jukkola-Vuorinen A, Niederacher D, Kato S, Ishioka C, Hainaut P, Borresen-Dale AL (2006) The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. Clin Cancer Res 12: 1157-1167 (Pubitemid 43342504)
12. Peller S, Halevy A, Slutzki S, Kopilova Y, Rotter V (1995) p53 mutations in matched primary and metastatic human tumors. Mol Carcinogen 13: 166-172
13. Pharoah PD, Day NE, Caldas C (1999) Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br J Cancer 80: 1968-1973 (Pubitemid 29391282)
14. Piccirilli C, Saxena A, Robertson J, Clark W, Ikejiri B, Oldfield E, Ali I (1994) Allelic deletions on chromosome-17 and mutations in the p53 gene in tumors metastatic to brain. Int J Oncol 1: 37-42 (Pubitemid 24012556)
15. Purdie CA, Jordan LB, McCullough JB, Edwards SL, Cunningham J, Walsh M, Grant A, Pratt N, Thompson AM (2010) HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma. Histopathology 56: 702-707
16. Sharma M, Abraham J (2007) CNS metastasis in primary breast cancer. Expert Rev Anticancer Ther 7: 1561-1566 (Pubitemid 350303013)
17. Smith PD, Crossland S, Parker G, Osin P, Brooks L, Waller J, Philp E, Crompton MR, Gusterson BA, Allday MJ, Crook T (1999) Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type functions. Oncogene 18: 2451-2459 (Pubitemid 29206158)
18. Soussi T, Wiman KG (2007) Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell 12: 303-312 (Pubitemid 47539312)
19. Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R (2006) Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer 107: 696-704 (Pubitemid 44232661)
20. Walker DR, Bond JP, Tarone RE, Harris CC, Makalowski W, Boguski MS, Greenblatt MS (1999) Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 structural and functional features. Oncogene 18: 211-218 (Pubitemid 29060595)